| MYAS1 |
|
Myasthenia gravis with thymus hyperplasia
|
|
|
1.000 |
0.115 |
| FAM136A |
Q96C01
|
family with sequence similarity 136 member A
|
|
5.9E-04 |
0.890 |
0.154 |
| TMEM109 |
Q9BVC6
|
transmembrane protein 109
|
|
7.5E-05 |
0.861 |
0.192 |
| FHDC1 |
Q9C0D6
|
FH2 domain containing 1
|
|
6.3E-05 |
0.839 |
0.231 |
| MIR653 |
|
microRNA 653
|
|
|
0.769 |
0.269 |
| MSL2 |
Q9HCI7
|
MSL complex subunit 2
|
|
0.62 |
0.821 |
0.269 |
| ATP6V1G2 |
O95670
|
ATPase H+ transporting V1 subunit G2
|
Transporter
|
2.9E-03 |
0.839 |
0.269 |
| CDIPT |
O14735
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
|
0.13 |
0.890 |
0.269 |
| IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
| MUC21 |
Q5SSG8
|
mucin 21, cell surface associated
|
|
8.0E-02 |
0.743 |
0.346 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| PRSS16 |
Q9NQE7
|
serine protease 16
|
Enzyme
|
4.1E-07 |
0.792 |
0.346 |
| CNTFR |
P26992
|
ciliary neurotrophic factor receptor
|
Signaling
|
0.96 |
0.722 |
0.385 |
| GPANK1 |
O95872
|
G-patch domain and ankyrin repeats 1
|
|
3.2E-07 |
0.769 |
0.385 |
| IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
| DIPK1A |
Q5T7M9
|
divergent protein kinase domain 1A
|
|
0.58 |
0.743 |
0.423 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| UNC5A |
Q6ZN44
|
unc-5 netrin receptor A
|
Receptor
|
1.00 |
0.729 |
0.423 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| GPSM3 |
Q9Y4H4
|
G protein signaling modulator 3
|
|
0.29 |
0.751 |
0.423 |
| CHRND |
Q07001
|
cholinergic receptor nicotinic delta subunit
|
Ion channel
|
5.4E-09 |
0.641 |
0.462 |
| CHRNB1 |
P11230
|
cholinergic receptor nicotinic beta 1 subunit
|
Ion channel
|
5.0E-08 |
0.700 |
0.462 |
| CDS1 |
Q92903
|
CDP-diacylglycerol synthase 1
|
|
6.4E-04 |
0.647 |
0.462 |
| PPP6R2 |
O75170
|
protein phosphatase 6 regulatory subunit 2
|
Enzyme modulator
|
0.16 |
0.722 |
0.462 |
| CTSV |
O60911
|
cathepsin V
|
Enzyme
|
2.3E-07 |
0.716 |
0.462 |